TI
FBRX icon

Trexquant Investment’s Forte Biosciences FBRX Stock Holding History

Trexquant Investment’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.91M Buy
73,651
+60,735
+470% +$1.75M 0.01% 1014
2025
Q4 		$352K Buy
+12,916
New +$226K ﹤0.01% 1418
2021
Q3 		– Sell
-303
Closed -$255K – 1245
2021
Q2 		$255K Buy
+303
New +$273K 0.02% 793
2019
Q1 		– Sell
-137
Closed -$421K – 1085
2018
Q4 		$421K Buy
+137
New +$590K 0.03% 670

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Trexquant Investment's FBRX Position: Q1 2026 in Review

Trexquant Investment increased its Forte Biosciences (FBRX) stake by 470% in Q1 2026, buying an estimated $1.75M and bringing the position to 73,651 shares worth $1.91M. The position accounts for 0.01% of the portfolio, ranked #1014.

Trexquant Investment first reported a position in FBRX in Q4 2018 and has held it in 4 quarters since. 68 funds tracked by Wall St. Rank hold FBRX as of Q1 2026.

  • Trexquant Investment held 73,651 shares of Forte Biosciences worth $1.91M as of Q1 2026.
  • Trexquant Investment bought 60,735 Forte Biosciences shares in Q1 2026, an estimated $1.75M.
  • Forte Biosciences made up 0.01% of Trexquant Investment's portfolio in Q1 2026, its #1014 holding.
  • Trexquant Investment first reported a position in Forte Biosciences in Q4 2018 and has held it in 4 quarters since.
  • 68 funds tracked by Wall St. Rank held Forte Biosciences as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.